Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Tularemia as a biological weapon: medical and public health management.
OBJECTIVE The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if tularemia is used as a… Expand
Botulinum toxin as a biological weapon: medical and public health management.
People potentially exposed to botulinum toxin should be closely observed, and those with signs of botulism require prompt treatment with antitoxin and supportive care that may include assisted ventilation for weeks or months. Expand
Anthrax as a biological weapon, 2002: updated recommendations for management.
This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the Anthrax Attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination. Expand
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Specific recommendations are made regarding smallpox vaccination, therapy, postexposure isolation and infection control, hospital epidemiology and infection Control, home care, decontamination of the environment, and additional research needs. Expand
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
The final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members. Expand
Hemorrhagic fever viruses as biological weapons: medical and public health management.
Weapons disseminating a number of HFVs could cause an outbreak of an undifferentiated febrile illness 2 to 21 days later, associated with clinical manifestations that could include rash, hemorrhagic diathesis, and shock. Expand
Augmentation of hospital critical care capacity after bioterrorist attacks or epidemics: Recommendations of the Working Group on Emergency Mass Critical Care‡
- Lewis Rubinson, J. Nuzzo, D. Talmor, T. O'Toole, Bradley R Kramer, T. Inglesby
- Critical care medicine
- 1 October 2005
The Working Group on Emergency Mass Critical Care was convened by the Center for Biosecurity of the University of Pittsburgh Medical Center and the Society of Critical Care Medicine to provide… Expand
Death due to bioterrorism-related inhalational anthrax: report of 2 patients.
Clinicians have an urgent need for prompt communication of vital epidemiologic information that could focus their diagnostic evaluation, and rapid diagnostic assays to distinguish more common infectious processes from agents of bioterrorism also could improve management strategies. Expand
A plague on your city: observations from TOPOFF.
- T. Inglesby, R. Grossman, T. O'Toole
- Clinical infectious diseases : an official…
- 1 February 2001
The TOPOFF exercise illuminated problematic issues of leadership and decision-making; the difficulties of prioritization and distribution of scarce resources; the crisis that contagious epidemics would cause in health care facilities; and the critical need to formulate sound principles of disease containment. Expand